High-Level Expression of Chemokine CXCL16 by Tumor Cells Correlates with a Good Prognosis and Increased Tumor-Infiltrating Lymphocytes in Colorectal Cancer
Open Access
- 15 May 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (10) , 4725-4731
Abstract
CXCL16 is a new member of the chemokine superfamily, which exists in a transmembrane as well as a soluble form. Its receptor CXCR6 is detected on CD4+ T cells, CD8+ T cells, and natural killer T cells. Here, we report a significant correlation of CXCL16 expression by tumor cells with the infiltration of T cells and prognosis in colorectal cancer (CRC). We first found that CXCL16 expression was consistently up-regulated more in tumor tissues than in normal mucosa derived from the same CRC patients. Four human CRC cell lines also expressed CXCL16 mRNA and secreted soluble CXCL16. We next examined the expression of CXCL16 and infiltration of lymphocytes in CRC specimens (n = 58) by immunohistochemistry. CRC patients with high levels of CXCL16 expression (n = 43) had higher levels of CD4+ and CD8+ tumor-infiltrating lymphocytes (TIL; P < 0.01) than those with low levels of CXCL16 expression (n = 15). Furthermore, the high CXCL16 expression group showed significantly better prognosis than the low CXCL16 expression group (P < 0.05). Collectively, our data suggest that the expression of CXCL16 by tumor cells enhances the recruitment of TILs, thereby bringing about a better prognosis in CRC. Thus, CXCL16 is a new prognostic biomarker and may be useful for the development of a more effective therapeutic strategy for CRC. [Cancer Res 2007;67(10):4725–31]Keywords
This publication has 35 references indexed in Scilit:
- RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4Clinical & Experimental Metastasis, 2006
- Pathogenic role of the CXCL16–CXCR6 pathway in rheumatoid arthritisArthritis & Rheumatism, 2005
- Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cellsEuropean Journal of Immunology, 2005
- Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver SinusoidsPLOS Biology, 2005
- Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal CancerClinical Cancer Research, 2005
- Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cellsJournal of Leukocyte Biology, 2003
- Bonzo/CXCR6 expression defines type 1–polarized T-cell subsets with extralymphoid tissue homing potentialJournal of Clinical Investigation, 2001
- Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on MacrophagesJournal of Biological Chemistry, 2000
- Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesisThe Journal of Pathology, 2000
- STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1Journal of Experimental Medicine, 1997